# Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan

> **NCT00212693** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 165 (—)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** ONO-2506PO

## Key facts

- **NCT ID:** NCT00212693
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2005-09
- **Final completion:** —
- **Target enrollment:** 165 (—)
- **Last updated:** 2012-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212693, "Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00212693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*